Narragansett Bancorp, Inc. Common Stock（NARA）財務資料NARANarragansett Bancorp, Inc. Common Stock

Evaluating the bottom line, Narragansett Bancorp, Inc. maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is 9.83%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively NARA converts its operational activities into shareholder value.

Sanara Medtech has shown fluctuating revenue with a recent total revenue of $27,798,534 in Q1 2026, but it has also reported negative net income in multiple quarters, with a net income of $458,957 in Q1 2026, indicating instability. The gross margin remains strong at 90.76%, which is a positive sign for profitability.